Researcher.Life Logo

DERMATOLOGY AND THERAPY : Impact Factor & More

eISSN: 2190-9172pISSN: 2193-8210
JournalOpen Access

Key Metrics

H-Index
38
Scite Index
0.91 5-Year SI
SJR
Q1Dermatology
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on DERMATOLOGY AND THERAPY

DERMATOLOGY AND THERAPY Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ADIS INT LTD
Language English
Frequency Quarterly
Article Processing ChargesEUR 5500 | USD 6850 | GBP 0
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2011
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in DERMATOLOGY AND THERAPY ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in DERMATOLOGY AND THERAPY

Epigenetic Skin Aging and Its Reversal to Improve Skin Longevity across Ethnicities and Phototypes Using a Dihydromyricetin-Containing Serum: Results from a Prospective, Single-Cohort Study.
  • 25 Apr 2026
  • Dermatology and therapy
Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial.
  • 25 Apr 2026
  • Dermatology and therapy
Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World Study.
  • 24 Apr 2026
  • Dermatology and therapy
Treatment Patterns and Economic Burden in ModeratetoSevere Chronic Hand Eczema in the USA: A Real-World Retrospective Claims Analysis.
  • 24 Apr 2026
  • Dermatology and therapy
Efficacy, Safety, and Tolerability of a Wearable Electrotrichogenic Device in Men with Androgenetic Alopecia: A Randomized, Double-Blind, Sham-Controlled Trial.
  • 22 Apr 2026
  • Dermatology and therapy
Beyond the Skin: Assessing Itch in Atopic Dermatitis - Insights from UK Dermatologists. A Cross-Sectional Survey and Narrative Review.
  • 21 Apr 2026
  • Dermatology and therapy
Epigenetic Skin Aging and Its Reversal to Improve Skin Longevity across Ethnicities and Phototypes Using a Dihydromyricetin-Containing Serum: Results from a Prospective, Single-Cohort Study.
  • 25 Apr 2026
  • Dermatology and therapy
Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial.
  • 25 Apr 2026
  • Dermatology and therapy
Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World Study.
  • 24 Apr 2026
  • Dermatology and therapy
Treatment Patterns and Economic Burden in ModeratetoSevere Chronic Hand Eczema in the USA: A Real-World Retrospective Claims Analysis.
  • 24 Apr 2026
  • Dermatology and therapy
Efficacy, Safety, and Tolerability of a Wearable Electrotrichogenic Device in Men with Androgenetic Alopecia: A Randomized, Double-Blind, Sham-Controlled Trial.
  • 22 Apr 2026
  • Dermatology and therapy
Beyond the Skin: Assessing Itch in Atopic Dermatitis - Insights from UK Dermatologists. A Cross-Sectional Survey and Narrative Review.
  • 21 Apr 2026
  • Dermatology and therapy

FAQs on DERMATOLOGY AND THERAPY